Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06069245 · ClinicalTrials.gov registry record · NA
MitoQ & Cardiopulmonary Responses During Exercise
A NA study, sponsored by Ball State University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT06069245: Completed NA study, sponsored by Ball State University.
NCT06069245 is a NA study that has completed, run by Ball State University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06069245, a NA study, has completed, sponsored by Ball State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Study Purpose: To examine the acute effects of antioxidant supplementation on energy use during a single bout of exercise in apparently healthy adult men and women. Specifically this study examined the acute effect of MitoQ on: 1. cardiopulmonary responses to submax and maximal exercise 2. Energy expenditure and fat/carbohydrate oxidation during sub maximal exercise. In a double-blind, randomized, placebo controlled, cross-over study design, participants performed 2 experimental trials which differed only in the supplement consumed (MitoQ or Placebo). Participants performed identical exercise protocols which consisted of a series of submaximal workloads followed by a ramp protocol to volitional exhaustion.
Primary Outcome
VO2max
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT MitoQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-09-14 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
What the finished NCT06069245 record still lists
NCT06069245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06069245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06069245 about?
NCT06069245 is a clinical study titled "MitoQ & Cardiopulmonary Responses During Exercise". Study Purpose: To examine the acute effects of antioxidant supplementation on energy use during a single bout of exercise in apparently healthy adult men and women. Specifically this study examined the acute effect of MitoQ on: 1. cardiopulmonary responses to submax and maximal exercise 2. Energy ...
What is the current status of trial NCT06069245?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2022-09-14. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT06069245?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), MitoQ (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06069245?
This trial is sponsored by Ball State University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06069245's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI